NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $13,000 | -13.3% | 24,969 | +13.3% | 0.00% | -100.0% |
Q2 2020 | $15,000 | -16.7% | 22,043 | -9.5% | 0.00% | 0.0% |
Q1 2020 | $18,000 | -33.3% | 24,349 | +36.3% | 0.00% | -50.0% |
Q4 2019 | $27,000 | +35.0% | 17,864 | +31.7% | 0.00% | +100.0% |
Q3 2019 | $20,000 | +185.7% | 13,562 | +146.6% | 0.00% | – |
Q2 2019 | $7,000 | -66.7% | 5,500 | -30.7% | 0.00% | -100.0% |
Q1 2019 | $21,000 | +2000.0% | 7,935 | +1487.0% | 0.00% | – |
Q4 2018 | $1,000 | -97.9% | 500 | -94.8% | 0.00% | -100.0% |
Q3 2018 | $47,000 | +123.8% | 9,703 | +289.5% | 0.00% | +50.0% |
Q1 2018 | $21,000 | +110.0% | 2,491 | +117.6% | 0.00% | +100.0% |
Q3 2017 | $10,000 | – | 1,145 | – | 0.00% | – |
Q2 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q1 2017 | $22,000 | +4.8% | 3,017 | -16.7% | 0.00% | 0.0% |
Q4 2016 | $21,000 | +133.3% | 3,622 | +271.1% | 0.00% | +100.0% |
Q2 2016 | $9,000 | +50.0% | 976 | +69.4% | 0.00% | 0.0% |
Q1 2016 | $6,000 | -89.7% | 576 | -79.3% | 0.00% | -83.3% |
Q3 2015 | $58,000 | – | 2,781 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 4,858,889 | $7,337,000 | 5.11% |
Proxima Capital Management, LLC | 170,294 | $257,000 | 0.77% |
SPHERA FUNDS MANAGEMENT LTD. | 3,530,731 | $5,331,000 | 0.44% |
Nantahala Capital Management | 4,610,000 | $6,961,000 | 0.21% |
Wealthstar Advisors, LLC | 73,295 | $111,000 | 0.07% |
Alambic Investment Management, L.P. | 51,733 | $78,000 | 0.06% |
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 100,000 | $151,000 | 0.05% |
BCS Wealth Management | 29,520 | $45,000 | 0.03% |
Allred Capital Management, LLC | 24,995 | $37,742,000 | 0.02% |
ALGERT GLOBAL LLC | 34,254 | $52,000 | 0.02% |